Calix Limited

PINK:CLXLF USA Specialty Chemicals
Market Cap
$217.73 Million
Market Cap Rank
#15667 Global
#6123 in USA
Share Price
$1.01
Change (1 day)
+0.00%
52-Week Range
$1.01 - $1.01
All Time High
$1.24
About

Calix Limited, an environmental technology company, provides industrial solutions to address global decarbonisation and sustainability challenges in Australia, Asia-Pacific, the United States, Europe, the Middle East, and Africa. It operates through Magnesia, Leilac, and Sustainable Processing (SusPro) segments. The company's solutions include ACTI-Mag, a wastewater solution; AQUA-Cal+, a water c… Read more

Calix Limited (CLXLF) - Net Assets

Latest net assets as of June 2025: $87.55 Million USD

Based on the latest financial reports, Calix Limited (CLXLF) has net assets worth $87.55 Million USD as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($110.38 Million) and total liabilities ($22.83 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $87.55 Million
% of Total Assets 79.32%
Annual Growth Rate 27.26%
5-Year Change 129.49%
10-Year Change N/A
Growth Volatility 53.36

Calix Limited - Net Assets Trend (2020–2025)

This chart illustrates how Calix Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Calix Limited (2020–2025)

The table below shows the annual net assets of Calix Limited from 2020 to 2025.

Year Net Assets Change
2025-06-30 $87.55 Million +4.22%
2024-06-30 $84.00 Million -19.96%
2023-06-30 $104.96 Million +134.30%
2022-06-30 $44.80 Million +17.43%
2021-06-30 $38.15 Million +45.43%
2020-06-30 $26.23 Million --

Equity Component Analysis

This analysis shows how different components contribute to Calix Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 9306551900.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (June 2025)

Component Amount Percentage
Other Components $208.61 Million 236.28%
Total Equity $88.29 Million 100.00%

Calix Limited Competitors by Market Cap

The table below lists competitors of Calix Limited ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Calix Limited's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 83,793,000 to 88,289,000, a change of 4,496,000 (5.4%).
  • Net loss of 19,172,000 reduced equity.
  • Share repurchases of 1,107,000 reduced equity.
  • New share issuances of 22,094,000 increased equity.
  • Other factors increased equity by 2,681,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income $-19.17 Million -21.72%
Share Repurchases $1.11 Million -1.25%
Share Issuances $22.09 Million +25.02%
Other Changes $2.68 Million +3.04%
Total Change $- 5.37%

Book Value vs Market Value Analysis

This analysis compares Calix Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.46x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 5.67x to 2.46x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2020-06-30 $0.18 $1.01 x
2021-06-30 $0.24 $1.01 x
2022-06-30 $0.27 $1.01 x
2023-06-30 $0.57 $1.01 x
2024-06-30 $0.46 $1.01 x
2025-06-30 $0.41 $1.01 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Calix Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -21.72%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -69.11%
  • • Asset Turnover: 0.25x
  • • Equity Multiplier: 1.25x
  • Recent ROE (-21.72%) is above the historical average (-27.11%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2020 -26.98% -50.32% 0.33x 1.63x $-9.70 Million
2021 -23.87% -47.41% 0.37x 1.35x $-12.92 Million
2022 -37.57% -88.47% 0.30x 1.41x $-20.69 Million
2023 -22.35% -124.66% 0.15x 1.23x $-33.56 Million
2024 -30.15% -85.78% 0.26x 1.34x $-33.64 Million
2025 -21.72% -69.11% 0.25x 1.25x $-28.00 Million

Industry Comparison

This section compares Calix Limited's net assets metrics with peer companies in the Specialty Chemicals industry.

Industry Context

  • Industry: Specialty Chemicals
  • Average net assets among peers: $7,181,833,981
  • Average return on equity (ROE) among peers: 7.11%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Calix Limited (CLXLF) $87.55 Million -26.98% 0.26x $176.92 Million
AirBoss of America Corp (ABSSF) $197.00 Million -16.19% 1.24x $57.06 Million
Asia Carbon Industries Inc (ACRB) $19.13 Million 17.11% 0.33x $0.98
Aimia Inc (AIMFF) $1.29 Billion -4.63% 2.83x $103.68 Million
L'Air Liquide S.A (AIQUF) $11.83 Billion 14.08% 1.26x $107.70 Billion
Akzo Nobel N.V (AKZOF) $7.58 Billion 14.03% 1.29x $9.73 Billion
Albemarle Corp (ALB) $545.00 Million 9.41% 1.09x $19.53 Billion
ALPEK S.A.B. de C.V (ALPKF) $49.59 Billion 15.64% 1.50x $214.40 Million
Altech Batteries Limited (ALTHF) $97.54 Million -5.87% 0.01x $27.89 Million
Arcadium Lithium plc (ALTM) $333.00 Million 14.14% 0.12x $6.26 Billion
Alto Ingredients Inc (ALTO) $345.21 Million 13.35% 0.40x $212.84 Million